U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07218705) titled 'A Study Of MCG In Cardiac Amyloidosis' on Oct. 16.
Brief Summary: The primary objective of this observational study is to evaluate the utility of magnetocardiography (MCG) in diagnosing and monitoring disease progression in patients with amyloidosis, and to assess its effectiveness in comparison to other modalities, such as ECG.
Study Start Date: Nov., 2025
Study Type: OBSERVATIONAL
Condition:
Amyloidosis
Intervention:
DEVICE: SandboxAQ CardiAQ Magnetocardiography
Magnetocardiography is a non-invasive, radiation-free imaging technique that detects the magnetic field generated by the electrical activity of the heart.
Recruitm...